CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (5,641,331)	$ (1,948,210)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	78,954	1,179
Preferred A stock issued to consultants		0
Amortization of right-to-use asset	71,349	0
Gain on settlement of notes payable	(1,836)	0
Gain on settlement of accounts payable	0	(397,962)
Gain on conversion of accrued salary	0	(6,988)
Gain (Loss) on revaluation of derivative liabilities	493,455	(498,095)
Derivative expense	0	125,869
Amortization of loan fees	0	18,000
Amortization of discount on notes payable	756,795	785,724
Stock based compensation	761,222	259,307
Changes in assets and liabilities:
Accounts receivables	(7,319)	0
Prepaid expenses	(28,844)	5,937
Due from related party	0	0
Inventory	(22,794)	0
Accrued liabilities	1,651,191	371,972
Operating lease liability	59,920	0
Other current liabilities	880	1,634
Accrued interest	203,447	89,642
Net cash used in operating activities	(1,624,911)	(1,191,991)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid for acquisition of fixed assets	(2,300,338)	0
Net cash used in investing activities	(2,300,338)	0
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from private placement of common stock	1,668,000	0
Proceeds from sales of Series C Preferred Stock, net of fees	2,760,000	0
Proceeds from notes payable, net of discount	0	1,381,406
Proceeds from sale of common stock	51,500	0
Principal payments on notes payable	(177,534)	(171,000)
Net cash provided by financing activities	4,301,966	1,210,406
Net increase (decrease) in cash and cash equivalents	376,717	18,415
Cash and cash equivalents at beginning of period	64,789	83,245
Cash and cash equivalents at end of period	441,506	101,660
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid	2,680	2,680
Income taxes paid	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock issued for conversion of debt and accrued interest	2,653,795	0
Settlement of derivative liabilities	(1,301,137)	1,020,449
Cashless exercise of warrants	0	50,986
Issued of Series A Preferred Stock to consultants	421,559	29,336
Preferred stock dividend	115,047	56,143
Deemed dividends on Preferred Stock	332,242	0
Derivative discounts	0	999,800
Shares issued for debt conversion		617,000
Shares issued for accrued salary conversion	127,910	17,787
Accrued interest converted to equity		36,983
Accounts Payable [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion to common stock	102,333	0
Accrued Payroll [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion to common stock	50,000	0
Stock Subscribed [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion to common stock	156,441
Series A Preferred Stock [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issued of Series A Preferred Stock to consultants	0	71,558
Preferred stock dividend	1,000	3,967
Conversion of Preferred stock to common stock	6,000	0
Series X Preferred Stock [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Preferred stock dividend	46,677	49,176
Conversion of Preferred stock to common stock	$ 61,781	$ 0